目前基于小分子的药物化学方法用于神经退行治疗疗法
Nitesh Sanghai1, Billy Vuong1, Ahmet Burak Berk1
1College of Pharmacy, Rady Faculty of Health Science, University of Manitoba, Winnipeg, MB R3E 0T5, Canada.
ChemMedChem
|February 8, 2024
概括
药物化学家正在开发新的小型有机分子来治疗神经退行性疾病 (NDD). 战略重点是克服血脑屏障 (BBB) 并针对多个途径以改善治疗结果.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药物发现 药物发现 药物发现
背景情况:
- 像阿尔茨海默病,帕金森病和ALS这样的神经退行性疾病 (NDD) 的病因复杂,有效治疗方法有限.
- 尽管进行了数十年的研究,但对于NDD存在药物短缺,部分原因是血脑屏障 (BBB) 阻碍了药物输送.
- NDD的多因素性质需要创新的治疗策略.
研究的目的:
- 审查和突出药物化学家在设计NDDs的小型有机分子时使用的新策略.
- 提高对新兴神经退行性疗法和其发展中的挑战的认识.
- 探索克服BBB和准复杂疾病途径的方法.
主要方法:
- 设计脂性小分子来增强大脑透.
- 利用前药物策略来改善药物输送和疗效.
- 采用多目标方法来调节与NDD相关的各种生化途径.
- 利用基于网络的计算工具来优化中枢神经系统 (CNS) 的候选药物.
- 实施体外BBB模型用于小有机分子临床前查.
主要成果:
- 药物化学家正在积极开发针对NDD的基于小分子的先进治疗策略.
- 正在探索新的方法来应对BBB带来的挑战.
- 计算工具和体外BBB模型正在帮助选择有前途的候选药物.
- 多重定位剂的发展显示出对调节复杂的NDD路径的前景.
结论:
- 药用化学为开发神经退行性疾病的新疗法提供了有前途的途径.
- 克服BBB仍然是一个关键的挑战,通过脂友性设计和预药等策略来解决.
- 计算,体外和多目标方法的结合对于推进NDD疗法至关重要.
相关概念视频
Alzheimer's Disease: Treatment
189
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
189
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Neurochemical Transmission: Sites of Drug Action
2.3K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.3K
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
125
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
125
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K


